Ruiz and colleagues [47] and Lange and colleagues [48] have associated triggering of glioma cell migration with a simultaneous mechanism of competitive inhibition of syndecan-4 binding of fibronectin and signalling by lysophosphatidic acid and platelet-derived growth factor (reviewed in [49]). The gene discussed is SDC4; the disease is central nervous system cancer.